LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.56234
71.54 771.67 4604 10532 0.4371 0.6059
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
73.76 771.67 5177 10851 0.4771 0.6472
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
73.76 771.67 4794 10851 0.4418 0.6144
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
76.02 771.67 5362 11106 0.4828 0.6551
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
76.02 771.67 4977 11106 0.4481 0.6234
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
78.25 771.67 5568 11367 0.4898 0.6640
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
78.25 771.67 5230 11367 0.4601 0.6374
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
80.48 771.67 5734 11685 0.4907 0.6679
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
80.48 771.67 5481 11685 0.4691 0.6488
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
82.69 771.67 5933 11974 0.4955 0.6747
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
82.69 771.67 5608 11974 0.4684 0.6510
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
84.92 771.67 6130 12266 0.4997 0.6809
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
84.92 771.67 5821 12266 0.4745 0.6592
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
87.14 771.67 6357 12592 0.5048 0.6879
MN20160304_L01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
87.14 771.67 6105 12592 0.4848 0.6710
MN20160304_L01
L15
MCF 10A-H2B-mCherry Dasatinib
1
2.49 771.67 731 867 0.8424 -0.2737
MN20160304_L01
E05
MCF 10A-H2B-mCherry Dasatinib
1
2.49 771.67 783 867 0.9023 0.0899
MN20160304_L01
G04
MCF 10A-H2B-mCherry Dasatinib
1
4.71 771.67 841 956 0.8794 0.3204
MN20160304_L01
E05
MCF 10A-H2B-mCherry Dasatinib
1
4.71 771.67 907 956 0.9484 0.6853
MN20160304_L01
G04
MCF 10A-H2B-mCherry Dasatinib
1
6.94 771.67 937 1045 0.8965 0.5583
MN20160304_L01
E05
MCF 10A-H2B-mCherry Dasatinib
1
6.94 771.67 1002 1045 0.9587 0.8164
MN20160304_L01
G04
MCF 10A-H2B-mCherry Dasatinib
1
9.16 771.67 1001 1138 0.8792 0.5900
MN20160304_L01
E05
MCF 10A-H2B-mCherry Dasatinib
1
9.16 771.67 1067 1138 0.9372 0.7817
MN20160304_L01
G04
MCF 10A-H2B-mCherry Dasatinib
1
11.56 771.67 1150 1280 0.8980 0.7262
MN20160304_L01
E05
MCF 10A-H2B-mCherry Dasatinib
1
11.56 771.67 1191 1280 0.9300 0.8110
MN20160304_L01
G04